by The global Asthma Spacers Market is estimated to be valued at US$ 1.86 Bn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview
Asthma spacers, also known as plastic chambers or valved holding chambers, are devices used with pressurized metered dose inhalers (pMDIs) to ensure appropriate drug delivery and sufficient coordination between actuation and inhalation. Asthma spacers provide advantages like improved delivery of medication to the lungs and reduced oropharyngeal deposition.
Market key trends
One of the key trends in the asthma spacers market is the introduction of new product variants by major players. Manufacturers are focusing on developing innovative spacer devices integrated with add-on features like dose counters, training masks for pediatric patients, and additional dose delivery indicators. These features help improve medication adherence and efficacy. Asthma spacers integrated with digital devices like apps are also gaining popularity. Connected spacers provide remote monitoring capabilities and automated dose reminding to caregivers and patients.
SWOT Analysis
Strength: Asthma spacers help deliver medications effectively and precisely to the lungs. They reduce intake of steroids and make the medications more patient-friendly.
Weakness: Spacers require regular cleaning and maintenance which can be inconvenient for some patients. The devices are made of plastic which gets more susceptive to bacterial growth over time.
Opportunity: Rising prevalence of asthma globally increases the potential patient pool. Growing health awareness drives the demand for effective asthma management devices like spacers.
Threats: Alternative devices and therapy methods can replace the conventional use of spacers. Regulatory hurdles in approval and stringent quality standards pose threats.
Key TakeawaysÂ
The global Asthma Spacers Market Share is expected to witness high growth, exhibiting CAGR of 6.7% over the forecast period, due to increasing prevalence of asthma worldwide. As per the latest World Health Organization data, over 300 million people suffer from asthma globally.
Regional analysis: North America dominates the global market owing to developed healthcare infrastructure and growing adoption of innovative respiratory devices. Asia Pacific demonstrates fast growth aided by booming medical tourism, rising healthcare spends and expanding patient base. China, India and Japan emerge as highly lucrative markets in the region.
Key players operating in the Asthma Spacers market are Trudell Medical International, PARI Respiratory Equipment, Inc., Koninklijke Philips N.V, GlaxoSmithKline Plc., Lupin, Medical Developments International, Visiomed Group Ltd., Cipla Inc., Clement Clarke International Ltd., Rossmax International Ltd., Luckys Pharma, Mediacare Equipments (India) Pvt. Ltd., Asia Connection Co., Ltd., and Laboratoire Protecsom SAS. The major players focus on developing advanced technologies and expanding geographical presence to strengthen their market position.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
